Hexarelin functions as a multi-pathway peptide agonist influencing endocrine signaling, downstream cascades, and vascular responses through multiple target receptor pathways. As a synthetic hexapeptide secretagogue-type compound that acts as a potent agonist with enhanced stability and potency compared to natural ligands, Hexarelin demonstrates broad signaling activity. Research models examine Hexarelin’s effects on pulsatile dynamics, downstream pathway stimulation, vascular signaling, and endocrine modulation in laboratory and preclinical experimental settings, with particular interest in its vascular and systemic actions.

Hexarelin belongs to the growth hormone-releasing peptide (GHRP) family, a class of synthetic secretagogues known for their ability to engage GHS-R1a in laboratory models. Structurally, it is a six-amino-acid peptide derived from the GHRP-6 scaffold, engineered for improved metabolic stability and enhanced receptor potency compared to native ghrelin.

What distinguishes Hexarelin as a research compound is its multi-pathway receptor profile. Beyond GHS-R1a engagement, in-vitro studies have identified functional interactions with the CD36 scavenger receptor,  linking Hexarelin to observable effects on lipid uptake and metabolism in cell-based models, as well as documented vascular signaling activity in endothelial and smooth muscle cell preparations. This broad target engagement makes it a versatile tool compound across several preclinical research disciplines.

All Hexarelin supplied through this repository is intended strictly for laboratory research, in-vitro experimentation, and scientific education. It is not formulated for human or veterinary administration.

• CAS Number: 140703-51-1
• Molecular Weight: 887.04 g/mol
• Purity: ≥99%
• Also Known As: Hex, Examorelin (INN), GHRP-His (informal designation in select research literature)
• Chemical Formula: C₄₇H₅₈N₁₂O₆

In laboratory settings, Hexarelin binds selectively to the growth hormone secretagogue receptor 1a (GHS-R1a), a G protein-coupled receptor expressed in pituitary and hypothalamic cell preparations. A key feature observed in research models is its influence on pulsatile GH release dynamics. Hexarelin’s receptor engagement triggers downstream signaling cascades that modulate the amplitude and frequency of GH secretion patterns, distinguishing it from compounds that produce tonic, non-physiological release profiles.

Beyond the pituitary axis, Hexarelin engages vascular receptor pathways, with in-vitro and preclinical models documenting downstream signaling activity in endothelial and smooth muscle cell preparations. These vascular responses appear to operate through mechanisms partially independent of GHS-R1a, pointing to a broader multi-pathway agonist profile.

• Pulsatile GH Dynamics
• Vascular Signaling Research
• GHS-R1a Receptor Biology
• Lipid Metabolism Studies
• Cardiovascular Cellular Research
• Neuroscience Research